The purpose of this study is to discover whether the inhibition of the xanthine oxidase with
allopurinol leads to a reduction of the production of oxygen free radicals in patients with
CHF and thereby improves characteristics of oxydative metabolism, peripheral blood flow,
immune function and functional status.